XML 12 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Balances, at Beginning of period at Dec. 31, 2022 $ 197,546 $ 3 $ 408,333 $ (1,813) $ (208,977)
Balances, at Beginning of period (in shares) at Dec. 31, 2022   40,287,097      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares under equity private placement, net of issuance costs of $240 (in shares)   13,211,381      
Issuance of shares under equity private placement, net of issuance costs of $240 129,760 $ 1 129,759    
Stock-based compensation expense 12,574   12,574    
Exercise of stock options 2,443   2,443    
Exercise of stock options (in shares)   665,902      
Issuance of shares under the employee stock purchase plan 711   711    
Issuance of shares under the employee stock purchase plan (in shares)   270,541      
Employee stock purchase plan expense 331   331    
Vesting of early exercised stock options 80   80    
Vesting of early exercised stock options (in shares)   18,640      
Vesting of restricted stock awards (in shares)   147,955      
Net unrealized gain on marketable securities 1,572     1,572  
Net Income (Loss) (69,883)       (69,883)
Balances, at End of period at Sep. 30, 2023 275,134 $ 4 554,231 (241) (278,860)
Balances, at End of period (in shares) at Sep. 30, 2023   54,601,516      
Balances, at Beginning of period at Jun. 30, 2023 161,583 $ 3 419,456 (518) (257,358)
Balances, at Beginning of period (in shares) at Jun. 30, 2023   41,122,482      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares under equity private placement, net of issuance costs of $240 (in shares)   13,211,381      
Issuance of shares under equity private placement, net of issuance costs of $240 129,760 $ 1 129,759    
Stock-based compensation expense 4,019   4,019    
Exercise of stock options 891   891    
Exercise of stock options (in shares)   213,675      
Employee stock purchase plan expense 86   86    
Vesting of early exercised stock options 20   20    
Vesting of early exercised stock options (in shares)   4,660      
Vesting of restricted stock awards (in shares)   49,318      
Net unrealized gain on marketable securities 277     277  
Net Income (Loss) (21,502)       (21,502)
Balances, at End of period at Sep. 30, 2023 275,134 $ 4 554,231 (241) (278,860)
Balances, at End of period (in shares) at Sep. 30, 2023   54,601,516      
Balances, at Beginning of period at Dec. 31, 2023 253,895 $ 4 559,176 347 (305,632)
Balances, at Beginning of period (in shares) at Dec. 31, 2023   54,992,784      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares under at-the-market offering, net of issuance costs 22,787   22,787    
Issuance of shares under at-the-market offering, net of issuance costs (in shares)   1,772,278      
Stock-based compensation expense 15,818   15,818    
Exercise of stock options $ 1,110   1,110    
Exercise of stock options (in shares) 389,043 359,897      
Issuance of shares under the employee stock purchase plan $ 650   650    
Issuance of shares under the employee stock purchase plan (in shares)   70,701      
Employee stock purchase plan expense 441   441    
Vesting of restricted stock awards (in shares)   92,659      
Net unrealized gain on marketable securities 117     117  
Net Income (Loss) (95,907)       (95,907)
Balances, at End of period at Sep. 30, 2024 198,911 $ 4 599,982 464 (401,539)
Balances, at End of period (in shares) at Sep. 30, 2024   57,288,319      
Balances, at Beginning of period at Jun. 30, 2024 227,163 $ 4 594,261 (118) (366,984)
Balances, at Beginning of period (in shares) at Jun. 30, 2024   57,246,411      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 5,572   5,572    
Exercise of stock options 95   95    
Exercise of stock options (in shares)   41,908      
Employee stock purchase plan expense 54   54    
Net unrealized gain on marketable securities 582     582  
Net Income (Loss) (34,555)       (34,555)
Balances, at End of period at Sep. 30, 2024 $ 198,911 $ 4 $ 599,982 $ 464 $ (401,539)
Balances, at End of period (in shares) at Sep. 30, 2024   57,288,319